Sun Pharma gets favourable verdict in antitrust-litigation in U.S.
Image used for representational purposes. | Photo Credit: Reuters Sun Pharmaceutical Industries on Monday (August 17, 2026) said an appellate court in the United States has passed a judgment in favour of the company and its subsidiaries in the antitrust litigation, in the U.S., relating to a 2008 patent litigation settlement agreement with Pfizer concerning…
Read More “Sun Pharma gets favourable verdict in antitrust-litigation in U.S.” »